This is has been the best week of the year for plants in England: wisterias, tree peonies, the incomparable Paeonia mlokosewiczii, the first bearded irises, and everywhere towering horse-chestnuts of white or red. But I turn to this lowly, smelly wild plant […]
Giant cell arteritis is not a diagnosis we make readily in general practice, though in theory it can be made on clinical grounds without the necessity of a temporal artery biopsy […]
Trials of education and screening in primary care tend to be labour-intensive and end up with large drop-out rates and low yields. This educational outreach and screening programme for tuberculosis in Hackney was certainly labour-intensive, and in terms of case-finding, had a low yield: […]
“Does tonsillectomy beat watchful waiting in adults? […]
For those who don’t want – or can’t remember – to take a bisphosphonate tablet once a week, there is the option of spending a quarter of an hour once a year having an infusion of zoledronic acid. […]
SURVIVE is not a good acronym for a trial of inotropic drugs in decompensated heart failure: if there is one certainty in cardiac pharmacology, it is that inotropic drugs never improve survival. […]
Patricia Hewitt, Secretary of State for Health, has today made yet another statement — and another apology — in the Commons about the MTAS debacle. […]
Do we really need a new drug for angina? I think we do, because although we already have a choice of beta-blockers, nitrates, calcium channel blockers and potassium channel activators, there will always be some patients whose angina remains hard to control, and who are not suitable for revascularisation. […]
This study selected patients with “bipolar depression […]
Salt is of course a very good and necessary thing. […]